All Marketing authorization holders of medicine are hereby informed that 72nd Medicines Evaluation Committee held on 22nd November 2022 recommended not to register new products of topical preparations containing Clobetasol Propionate with an antifungal and not to renew or issue import license for existing topical preparations containing Clobetasol Propionate with an antifungal.

‍